CAPEK JOHN M
SEC CIK 1328034 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ABT | Abbott Laboratories | EVP | 339.4K | — | $20.20M | 6 | 2021-12-13 | 2023-02-28 |
Most active insiders at ABT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ford Robert B | COB AND CEO, Dir | $2.01M | $46.20M |
| 2 | STARKS DANIEL J | Dir | $2.01M | — |
| 3 | Morrone Louis H. | EVP | — | $774.7K |
| 4 | Shroff Eric | SVP | — | $285.0K |
| 5 | Boudreau Philip P | EVP AND CFO | $201.3K | — |
| 6 | Stratton John G | Dir | $173.6K | — |
| 7 | Salvadori Daniel Gesua Sive | EVP AND GROUP Pres | — | $102.3K |
| 8 | Moreland Mary K | EVP | — | $70.9K |
| 9 | MCCOY JOHN A. JR. | VP AND Ctrl | — | $70.6K |
| 10 | Cushman Elizabeth C. | EVP, GC AND Sec | — | $30.4K |
CAPEK JOHN M made no open-market trades at ABT in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-02 | 2023-02-28 | ABT | Abbott Laboratories | CAPEK JOHN M | EVP | F - Tax | $99.77 | -6,247 | 339.4K | -2% | -$623.3K | |
| D | 2023-02-22 | 2023-02-17 | ABT | Abbott Laboratories | CAPEK JOHN M | EVP | A - Grant | $0.00 | +15.9K | 345.7K | +5% | $0 |
| 2022-03-02 | 2022-02-28 | ABT | Abbott Laboratories | CAPEK JOHN M | EVP | F - Tax | $122.41 | -7,086 | 329.8K | -2% | -$867.4K | |
| D | 2022-02-23 | 2022-02-18 | ABT | Abbott Laboratories | CAPEK JOHN M | EVP | A - Grant | $0.00 | +15.5K | 336.9K | +5% | $0 |
| D | 2021-12-15 | 2021-12-13 | ABT | Abbott Laboratories | CAPEK JOHN M | EVP | M - OptEx | $34.94 | +149.6K | 471.0K | +47% | +$5.23M |
| D | 2021-12-15 | 2021-12-13 | ABT | Abbott Laboratories | CAPEK JOHN M | EVP | S - Sale+OE | $135.05 | -149.6K | 321.4K | -32% | -$20.20M |
Purchase Sale Sale after option exercise All abbreviations